Cartesian Therapeutics (1S70.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-9.77
-6.35
-2.93
0.49

Details

Expected EPS
-0.74219132527
Actual EPS
-1.0461653
Surprise EPS
-0.3
Surprise Percent
+40.96%

Description

Cartesian Therapeutics (1S70.F) has reported earnings of -1.0461653 per share for Q4 2024.

0 Comments

Share your thoughts